Emory University receives $26 million to study AIDS vaccine

“Developing a safe and effective preventive HIV/AIDS vaccine is still a critical part of the fight against this challenging disease that affects more than 30 million people worldwide,” said Hunter. “With the vast experience of Emory’s vaccine researchers and our partners, I’m confident we can make significant strides in developing a better HIV vaccine.”

The study will be conducted at Emory’s Yerkes National Primate Research Center.

Emory University currently runs several programs aimed at reducing infection rates, increasing testing rates and providing counseling services to those infected. Emory University’s Center for AIDS Research includes more than 100 investigators working on basic, clinical, translational and behavioral projects, including vaccine research, according to the university.

For more information, click here.